Optimisation of Patient Centric Medicines for the Older Population

Dear Colleagues,

Improvements in healthcare and lifestyles have increased the proportion of people aged 65 and above, whilst this population also represents a major user group of prescribed medicines. Optimising the use of these medicines is important to ensure that these patients are willing and able to take their medication as intended in order to manage conditions effectively; however, age-related changes, the presence of co-morbidities and issues of acceptance and adherence can lead to complexities in medicines optimisation in this heterogeneous population.

This Special Issue serves to highlight and capture the contemporary progress and current landscape of patient-centric pharmaceutical drug product design, formulation and optimisation for the older population. We invite articles on all aspects of research focused on identifying, understanding and utilising the comprehensive needs and diverse complexities of this patient group in order to achieve optimum health outcomes, particularly those studies highlighting the requirements for a multidisciplinary approach, including the use of healthcare technologies.

Dr. Daniel J. Kirby
Dr. Mine Orlu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.